Evidence map›Paper›PMID 34799819›Full record

ArticleJournal of gastrointestinal cancer2023

Krukenberg Tumor Presentation of Recurrent Gallbladder Cancer After a Decade.

Barış Tuzcu, Osman Sütcüoğlu, Elif Kolay Bayram, Özlem Erdem, Ozan Yazıcı

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of gastrointestinal cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Barış TuzcuDepartment of Internal Medicine, Gazi University, Ankara, Turkey.ORCID http://orcid.org/0000-0002-8518-9927
Osman SütcüoğluDepartment of Medical Oncology, Gazi University, Ankara, Turkey.ORCID http://orcid.org/0000-0003-3835-2741
Elif Kolay BayramDepartment of Pathology, Gazi University, Ankara, Turkey.ORCID http://orcid.org/0000-0002-6456-7642
Özlem ErdemDepartment of Pathology, Gazi University, Ankara, Turkey.ORCID http://orcid.org/0000-0002-5981-4856
Ozan YazıcıDepartment of Medical Oncology, Gazi University, Ankara, Turkey.ORCID http://orcid.org/0000-0003-0038-3569
Gazi University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKrukenberg tumors are among rare cases of metastatic ovary cancers. They are presented as a solid mass which generally has bilateral and sometimes cystic components and is also known through symptoms related to the mass effect and/or hormonal imbalance. However, they may present findings before the primary tumor or remain asymptomatic for a long time. CASE REPORT: We presented a patient, who was diagnosed with gallbladder cancer nine years ago and whose adjuvant treatment was completed, applied to the outpatient clinic with the complaint of vaginal bleeding. Surgery was recommended to the patient and the patient was diagnosed with metastatic signet ring cell gallbladder cancer. The patient was started on gemcitabine-capecitabine treatment after surgery.

conclusionThe case is important both due to the rareness of metastasis of gall bladder cancer on the ovaries and also the detection of metastasis following the nine-year recurrence-free period. This case shows that routine controls including a careful gynecological examination in a patient primarily detected to have gastrointestinal malignity are important for recognizing late metastases.

Indexed as

Gallbladder NeoplasmsKrukenberg TumorOvarian NeoplasmsDiagnosis, DifferentialFemaleHumansGallbladderKrukenberg tumorMalignancyMetastasisOvary cancer

Identifiers

PMID34799819
OpenAlexW3212524475

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.